Envision Healthcare (NYSE:EVHC) was the target of a large increase in short interest in the month of March. As of March 29th, there was short interest totalling 24,458,190 shares, an increase of 12.8% from the March 15th total of 21,681,282 shares. Based on an average daily volume of 2,365,494 shares, the days-to-cover ratio is presently 10.3 days. Currently, 20.7% of the company’s shares are sold short.
EVHC stock opened at $38.13 on Tuesday. The company has a current ratio of 3.40, a quick ratio of 3.38 and a debt-to-equity ratio of 0.87. The stock has a market capitalization of $4,525.01, a price-to-earnings ratio of 15.38, a P/E/G ratio of 0.86 and a beta of 0.42. Envision Healthcare has a 1 year low of $23.77 and a 1 year high of $64.00.
Envision Healthcare (NYSE:EVHC) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.45 by $0.14. The company had revenue of $2 billion for the quarter, compared to analyst estimates of $1.97 billion. Envision Healthcare had a positive return on equity of 4.62% and a negative net margin of 2.52%. Envision Healthcare’s revenue for the quarter was up 68.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.15 EPS. equities analysts forecast that Envision Healthcare will post 3.34 EPS for the current fiscal year.
A number of hedge funds have recently bought and sold shares of EVHC. CIBC World Markets Inc. acquired a new stake in Envision Healthcare in the 4th quarter valued at about $208,000. OLD Mutual Customised Solutions Proprietary Ltd. raised its position in Envision Healthcare by 88.2% in the 4th quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 6,401 shares of the company’s stock valued at $221,000 after purchasing an additional 3,000 shares in the last quarter. CENTRAL TRUST Co raised its position in Envision Healthcare by 79.7% in the 4th quarter. CENTRAL TRUST Co now owns 6,626 shares of the company’s stock valued at $229,000 after purchasing an additional 2,939 shares in the last quarter. Alps Advisors Inc. acquired a new stake in Envision Healthcare in the 4th quarter valued at about $235,000. Finally, M&T Bank Corp raised its position in Envision Healthcare by 33.6% in the 4th quarter. M&T Bank Corp now owns 6,818 shares of the company’s stock valued at $235,000 after purchasing an additional 1,716 shares in the last quarter.
EVHC has been the topic of several research reports. Robert W. Baird reissued an “outperform” rating and set a $50.00 target price (up previously from $45.00) on shares of Envision Healthcare in a research note on Wednesday, March 7th. Mizuho set a $38.00 target price on Envision Healthcare and gave the stock a “hold” rating in a research note on Friday, March 2nd. Royal Bank of Canada reissued a “buy” rating and set a $48.00 target price on shares of Envision Healthcare in a research note on Thursday, March 1st. SunTrust Banks increased their target price on Envision Healthcare to $45.00 and gave the stock a “buy” rating in a research note on Thursday, March 1st. Finally, Jefferies Group set a $46.00 target price on Envision Healthcare and gave the stock a “buy” rating in a research note on Thursday, March 15th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $42.57.
About Envision Healthcare
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.